| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |